Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

Jamesbond820 Jun, 2023Health

Employ evidence-based strategies to integrate emerging immune checkpoint inhibitors and adoptive T-cell therapies into current clinical paradigms for advanced/metastatic melanoma. Among oncologists caring for melanoma patients, gaps have been identified in knowledge related to clinical data on novel therapies, how to sequence therapies, and the identification of appropriate patients associated with novel therapies.